Drug Shortage Report for ESOMEPRAZOLE
Report ID | 114022 |
Drug Identification Number | 02394839 |
Brand name | ESOMEPRAZOLE |
Common or Proper name | ESOMEPRAZOLE |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | ESOMEPRAZOLE |
Strength(s) | 20MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-05-04 |
Estimated end date | 2021-09-23 |
Actual end date | 2021-09-21 |
Shortage status | Resolved |
Updated date | 2021-09-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.